Cetera Investment Advisers’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
74,501
-736
| -1% | -$11.4K | ﹤0.01% | 2250 |
|
|
2025
Q1 | $1.12M | Buy |
75,237
+15,964
| +27% | +$237K | ﹤0.01% | 2174 |
|
|
2024
Q4 | $785K | Buy |
59,273
+7,574
| +15% | +$100K | ﹤0.01% | 2334 |
|
|
2024
Q3 | $735K | Buy |
51,699
+9,905
| +24% | +$141K | ﹤0.01% | 2343 |
|
|
2024
Q2 | $541K | Buy |
41,794
+5,201
| +14% | +$67.3K | ﹤0.01% | 2528 |
|
|
2024
Q1 | $508K | Buy |
36,593
+22,953
| +168% | +$319K | ﹤0.01% | 2593 |
|
|
2023
Q4 | $195K | Sell |
13,640
-1,214
| -8% | -$17.3K | ﹤0.01% | 2056 |
|
|
2023
Q3 | $230K | Sell |
14,854
-36
| -0.2% | -$557 | ﹤0.01% | 1893 |
|
|
2023
Q2 | $234K | Sell |
14,890
-1,117
| -7% | -$17.5K | ﹤0.01% | 1891 |
|
|
2023
Q1 | $264K | Buy |
+16,007
| New | +$264K | ﹤0.01% | 1779 |
|